Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma-Reference-Cited by-同舟云学术

Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma

Published:2019-09-28 Issue:3 Volume:59 Page:310-314
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Mattila Kalle E.¹²^ORCID,Vihinen Pia¹²,Ramadan Susan¹²,Skyttä Tanja³⁴,Tiainen Leena³⁴,Vuoristo Meri-Sisko³⁴,Tyynelä-Korhonen Kristiina⁵,Koivunen Jussi⁶,Kohtamäki Laura⁷,Mäkelä Siru⁷,Hernberg Micaela⁷^ORCID

Affiliation:

1. Fican West Cancer Centre, Department of Oncology and Radiotherapy, University of Turku, Turku, Finland;

2. Turku University Hospital, Turku, Finland;

3. Department of Oncology and Radiotherapy, Tampere University Hospital, Tampere, Finland;

4. Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland;

5. Center of Oncology, Kuopio University Hospital, Kuopio, Finland;

6. Department of Oncology and Radiotherapy, University of Oulu and Oulu University Hospital, Oulu, Finland;

7. HYKS Cancer Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2019.1670862

Reference18 articles.

1. New drugs in melanoma: It’s a whole new world

2. The History and Future of Chemotherapy for Melanoma

3. Metastatic melanoma: Chemotherapy

4. Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.

5. A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma;Acta Dermato-Venereologica;2023-02-07

2. Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor;Acta Oncologica;2022-10-03

3. Antitumor effect of Melaleuca alternifolia essential oil and its main component terpinen-4-ol in combination with target therapy in melanoma models;Cell Death Discovery;2021-05-31

4. BCL2L10 Is Overexpressed in Melanoma Downstream of STAT3 and Promotes Cisplatin and ABT-737 Resistance;Cancers;2020-12-30

5. Clinical Implications of Acquired BRAF Inhibitors Resistance in Melanoma;International Journal of Molecular Sciences;2020-12-20